Compare Novavax Inc (NVAX) vs PubMatic Inc (PUBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs PubMatic Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while PubMatic Inc trades at $13 (market cap $607.48M). The key difference: Novavax Inc is far larger — about 2.1× PubMatic Inc's market cap, and PubMatic Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | PUBM | |
|---|---|---|
Market Cap | $1.30B | $607.48M |
Sector | Health | Technology |
52-Week High | $11.19 | $13.83 |
52-Week Low | $6.22 | $6.28 |
Enterprise Value | $800.50M | $504.98M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About PubMatic Inc
PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →
